Menu
Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari has developed two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The company purpose-built its products for the specific characteristics of the venous system and the treatment of the two distinct manifestations of venous thromboembolism, or VTE: deep vein thrombosis and pulmonary embolism. The ClotTriever system is 510(k)-cleared by the FDA and CE Mark approved for the treatment of deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA and CE Mark approved for the treatment of pulmonary embolism and clot in transit in the right atrium.
As of Tuesday, Inari Medical Inc.’s (NASDAQ:NARI) stock closed at $54.64, down from $56.02 the previous day. While Inari Medical Inc. has underperformed by -2.46%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, NARI fell by -44.27%, with highs and lows ranging from $100.00 to $50.50, […]
Inari Medical (NARI) added ~5% pre-market Monday after announcing that its FDA-cleared FlowTriever cut the mortality risk by 90% in those with pulmonary embolism. Read the full story here.
Inari Medical has solid top-line growth with expansion in core and new product lines. Click here to read my most recent analysis of NARI stock.
Inari Medical, Inc. (NASDAQ:NASDAQ:NARI) Q4 2022 Earnings Conference Call February 27, 2023 4:30 PM ETCompany ParticipantsCaroline Corner - IRDrew Hykes - President and CEOMitch Hill -…
Inari Medical press release (NARI): Q4 GAAP EPS of -$0.11 beats by $0.06.Revenue of $107.8M (+29.5% Y/Y) beats by $2.95M.For the full year 2023, we are reaffirming our revenue…
IRVINE, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today reported financial results for its fourth quarter and full year ended December 31, 2022.
Inari Medical (NARI) is scheduled to announce Q4 earnings results on Monday, February 27th, after market close.The consensus EPS Estimate is -$0.17 and the consensus Revenue Estimate…
Inari Medical (NASDAQ: NARI ) is set to give its latest quarterly earnings report on Monday, 2023-02-27. Here''s what investors need to know before the announcement. Analysts estimate that Inari Medical will report an earnings per share (EPS) of $-0.17. Inari Medical bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the … Full story available on Benzinga.com
Canaccord Genuity analyst William Plovanic maintains Inari Medical (NASDAQ:NARI) with a Buy and raises the price target from $76 to $77.
The share price of Inari Medical Inc. (NASDAQ:NARI) rose to $59.13 per share on Wednesday from $55.63. While Inari Medical Inc. has overperformed by 6.29%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, NARI fell by -21.83%, with highs and lows ranging from $100.00 to $50.50, […]
Inari Medical Inc. (NASDAQ:NARI) marked $55.40 per share on Wednesday, down from a previous closing price of $56.54. While Inari Medical Inc. has underperformed by -2.02%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, NARI fell by -25.16%, with highs and lows ranging from $100.00 to […]
In the last trading session, 1.02 million shares of the Inari Medical Inc. (NASDAQ:NARI) were traded. Most recently the company’s share price was $56.54, and it changed around $0.29 or 0.52% from the last close, which brings the market valuation of the company to $3.04B. NARI currently trades at a discount to its 52-week high … Inari Medical Inc. (NASDAQ: NARI) Shares Are Heading Higher Read More »
IRVINE, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that it will release its fourth quarter and full year 2022 financial results on Monday, February 27, 2023. In conjunction with the release, Inari will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.
In Wednesday’s session, Inari Medical Inc. (NASDAQ:NARI) marked $57.39 per share, up from $57.05 in the previous session. While Inari Medical Inc. has overperformed by 0.60%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, NARI fell by -21.98%, with highs and lows ranging from $100.00 to […]